Skip to content

A clinical study to examine the safety and device procedural success of Relisys VEDA-R PTCA Dilatation catheter

VEDA-R1 Registry: Clinical Evaluation of Veda-R PTCA Dilatation Catheter - VPDC1

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/03/005641
Enrollment
60
Registered
2015-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with Coronary Artery Disorder

Interventions

Intervention1: Veda-R Dilatation Catheter: Veda-R NC and SC catheters are being tested in selected population

Sponsors

Relisys Medical Devices LTD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinical: 1. Patient â?? above 18 years of age and able to give informed consent. 2. Patient with stenotic lesions in coronary arteries or bypass graft stenosis that is suitable for percutaneous coronary intervention (PCI). 3. The patient has single or multiple vessel coronary artery disease and clinical evidence of ischemic heart disease, acute coronary syndrome, stable or unstable angina, silent ischemia, and/or a positive functional study. 4. Female patients of childbearing potential must have a negative pregnancy test within seven (7) days before the procedure. 5. Patient willing to give the consent. Angiographic: 6. Subject must have de novo or restenotic lesion(s) in native coronary arteries or bypass grafts that are suitable for percutaneous coronary intervention. 7. A maximum of three lesions, including at least one target lesion, in up to two coronary arteries. 8. Target and non-target lesions must be located in different coronary arteries or bypass grafts. 9. Target lesion(s) must have a diameter stenosis of >=70% by visual estimation

Exclusion criteria

Exclusion criteria: 1. During the index procedure, the target lesion requires additional treatment with a cutting balloon, any artherectomy, any laser, thrombectomy.

Design outcomes

Primary

MeasureTime frame
Procedural Success and Device SuccessTimepoint: During procedure

Secondary

MeasureTime frame
Major Adverse Cardiac EventsTimepoint: During procedure

Countries

India

Contacts

Public ContactS Prashanth

CARE Hospital

drnirmal_kumar@yahoo.com04030417777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026